The clinical-stage biotech might have a successful drug on its hands, if a relatively early-stage clinical trial is any indication. Its REC-4881 did very well in the testing. 10 stocks we like better ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback